全文获取类型
收费全文 | 678篇 |
免费 | 42篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 21篇 |
妇产科学 | 91篇 |
基础医学 | 59篇 |
口腔科学 | 4篇 |
临床医学 | 46篇 |
内科学 | 126篇 |
皮肤病学 | 11篇 |
神经病学 | 114篇 |
特种医学 | 18篇 |
外科学 | 122篇 |
综合类 | 2篇 |
预防医学 | 15篇 |
眼科学 | 4篇 |
药学 | 28篇 |
肿瘤学 | 38篇 |
出版年
2023年 | 2篇 |
2022年 | 8篇 |
2021年 | 11篇 |
2020年 | 6篇 |
2019年 | 15篇 |
2018年 | 31篇 |
2017年 | 13篇 |
2016年 | 13篇 |
2015年 | 20篇 |
2014年 | 17篇 |
2013年 | 32篇 |
2012年 | 32篇 |
2011年 | 37篇 |
2010年 | 27篇 |
2009年 | 18篇 |
2008年 | 48篇 |
2007年 | 38篇 |
2006年 | 64篇 |
2005年 | 51篇 |
2004年 | 55篇 |
2003年 | 30篇 |
2002年 | 36篇 |
2001年 | 5篇 |
2000年 | 4篇 |
1999年 | 6篇 |
1998年 | 6篇 |
1997年 | 8篇 |
1996年 | 9篇 |
1995年 | 9篇 |
1994年 | 6篇 |
1993年 | 2篇 |
1992年 | 8篇 |
1990年 | 3篇 |
1989年 | 5篇 |
1988年 | 5篇 |
1987年 | 5篇 |
1986年 | 3篇 |
1985年 | 2篇 |
1984年 | 9篇 |
1983年 | 7篇 |
1982年 | 3篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1975年 | 2篇 |
1973年 | 1篇 |
1970年 | 1篇 |
排序方式: 共有727条查询结果,搜索用时 15 毫秒
91.
E Naparstek Y Hardan M Ben-Shahar A Nagler R Or M Mumcuoglu L Weiss S Samuel S Slavin 《Blood》1992,80(7):1673-1678
We studied an alternative method of using hematopoietic growth factors (HGFs) to enhance hematopoietic recovery in patients undergoing bone marrow transplantation (BMT), by short in vitro preincubation. Twenty consecutive patients with leukemia received T-cell-depleted allografts using Campath-1G. Two thirds of the marrow was infused on the scheduled day of transplant and one third of the marrow following preincubation with granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3) on day 4. Engraftment parameters and duration of hospitalization were compared by actuarial analysis to those of 40 historical controls. Patients receiving the incubated boost had significantly faster platelet recovery (P = .017) and shorter hospitalization period (P = .001) when compared with the control subjects. Platelet count reached greater than 25 x 10(9)/L on day 17 (median) in the study group and on day 23 in the controls. The median duration of hospitalization was 20 and 36 days, respectively. In the early posttransplantation follow-up, two of four patients in the study group died as a result of graft rejection, while all 13 deaths in the control group resulted from complications associated with marrow suppression. We suggest that pretransplant in vitro activation of bone marrow cells with IL-3 and GM-CSF may prove to be an efficient method for enhancing marrow recovery after BMT. 相似文献
92.
93.
94.
95.
Dimitrios G Chatzis Kalliopi Magounaki Ioannis Pantazopoulos Sonu Menachem Maimonides Bhaskar 《World Journal of Clinical Cases》2022,10(27):9602-9610
The current coronavirus disease 2019 (COVID-19) pandemic has had devastating impact on populations around the world. The high mortality rates in patients with COVID-19 has been attributed to the influence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), its causative viral agent, on several physiological systems in human body, including the respiratory, cardiovascular, and neurological systems. There is emerging evidence on propensity of this virus to attack cardiovascular system. However, various pathophysiological mecha nisms by which SARS-CoV-2 interacts with cardiovascular system and leads to high morbidity and mortality, including cardiovascular complications, are poorly understood. This mini review aims to provide an update on the current know ledge and perspectives on areas of future research. 相似文献
96.
97.
Muna Qayed Tao Wang Michael T. Hemmer Stephen Spellman Mukta Arora Daniel Couriel Amin Alousi Joseph Pidala Hisham Abdel-Azim Mahmoud Aljurf Mouhab Ayas Menachem Bitan Mitchell Cairo Sung Won Choi Christopher Dandoy David Delgado Robert Peter Gale Gregory Hale John Horan 《Biology of blood and marrow transplantation》2018,24(3):521-528
Relapse remains the major cause of mortality after hematopoietic cell transplantation (HCT) for pediatric acute leukemia. Previous research has suggested that reducing the intensity of calcineurin inhibitor-based graft-versus-host disease (GVHD) prophylaxis may be an effective strategy for abrogating the risk of relapse in pediatric patients undergoing matched sibling donor (MSD) HCT. We reasoned that the benefits of this strategy could be maximized by selectively applying it to those patients least likely to develop GVHD. We conducted a study of risk factors for GVHD, to risk-stratify patients based on age. Patients age <18 years with leukemia who received myeloablative, T cell-replete MSD bone marrow transplantation and calcineurin inhibitor-based GVHD prophylaxis between 2000 and 2013 and were entered into the Center for International Blood and Marrow Transplant Research registry were included. The cumulative incidence of grade II-IV acute GVHD (aGVHD) was 19%, that of grade II-IV aGVHD 7%, and that of chronic GVHD (cGVHD) was 16%. Compared with age 13 to 18 years, age 2 to 12 years was associated with a lower risk of grade II-IV aGVHD (hazard ratio [HR], .42; 95% confidence interval [CI], .26 to .70; P?=?.0008), grade II-IV aGVHD (HR, .24; 95% CI, .10 to .56; P?=?.001), and cGVHD (HR, .32; 95% CI, .19 to .54; P?<?.001). Compared with 2000-2004, the risk of grade II-IV aGVHD was lower in children undergoing transplantation in 2005-2008 (HR, .36; 95% CI, .20 to .65; P?=?.0007) and in 2009-2013 (HR, .24; 95% CI. .11 to .53; P?=?.0004). Similarly, the risk of grade III-IV aGVHD was lower in children undergoing transplantation in 2005-2008 (HR, .23; 95% CI, .08 to .65; P?=?.0056) and 2009-2013 (HR, .16; 95% CI, .04 to .67; P?=?.0126) compared with those doing so in 2000-2004. We conclude that aGVHD rates have decreased significantly over time, and that children age 2 to 12 years are at very low risk for aGVHD and cGVHD. These results should be validated in an independent analysis, because these patients with high-risk malignancies may be good candidates for trials of reduced GVHD prophylaxis. 相似文献
98.
Malignant thymoma associated with progressive systemic sclerosis 总被引:3,自引:0,他引:3
M Ben-Shahar E Rosenblatt J Green I Cohen 《The American journal of the medical sciences》1987,294(4):262-267
A 65-year-old man manifested certain features of scleroderma several years before discovery of malignant thymoma. Following tumor resection, the signs and symptoms of scleroderma did not improve, and the patient experienced the abrupt onset of renal failure with malignant hypertension 7 months after the operation. The scleroderma renal crisis caused terminal renal failure, which was treated by chronic hemodialysis. This is the second reported case of thymoma associated with progressive systemic sclerosis (PSS). The authors suggest that thymoma and various immunologic disorders have a common etiologic factor which has not yet been found. This case emphasizes that thymectomy frequently has little effect on the course of the immunologic disease. The implications of the association of thymoma and PSS are discussed. 相似文献
99.